Processa Pharmaceuticals, Inc.

Informe acción NasdaqCM:PCSA

Capitalización de mercado: US$3.7m

Dividendos de Processa Pharmaceuticals

Dividendo controles de criterios 0/6

Processa Pharmaceuticals does not have a record of paying a dividend.

Información clave

n/a

Rentabilidad por dividendo

-191.1%

Rendimiento de la recompra

Rendimiento total para el accionista-191.1%
Rendimiento futuro de los dividendosn/a
Crecimiento de los dividendosn/a
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Ratio de pagon/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Dec 12
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Oct 20
Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73

Aug 12

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Jul 07
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Jan 20
We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Aug 26
Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Processa Pharmaceuticals (PCSA) Presents At LD Micro Invitations XI Virtual Conference - Slideshow

Jun 15

What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Mar 15
What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Processa Pharmaceuticals: Multiple Shots On Goal With Total TAM Of $8B - Worth A Look

Jan 29

How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

Jan 20
How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if PCSA's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if PCSA's dividend payments have been increasing.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Processa Pharmaceuticals vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de PCSA con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (PCSA)n/a
Suelo de mercado 25% (US)1.5%
Techo de mercado 25% (US)4.5%
Media de la industria (Pharmaceuticals)2.3%
Analista de previsiones (PCSA) (hasta 3 años)n/a

Dividendo destacado: Unable to evaluate PCSA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate PCSA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate PCSA's payout ratio to determine if its dividend payments are covered by earnings.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as PCSA has not reported any payouts.


Descubre empresas que pagan buenos dividendos